Osteonecrosis of the jaw has also been associated with IV bisphosphonates and is more common in those receiving high-dose and prolonged therapy and in those who have undergone dental procedures while on therapy.42, Calcitonin is also used to acutely lower calcium levels. This guideline has been adapted for local use. Wright et al4 found that either pamidronate or zoledronic acid was administered only to 54.2% of patients with hypercalcemia of malignancy within 48 hours of diagnosis and to 67.8% of patients overall. Clinical experience in 126 treated patients, Quality and outcomes of treatment of hypercalcemia of malignancy, Hypercalcemia of malignancy and new treatment options, From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health, Laboratory approaches for the diagnosis and assessment of hypercalcemia, (ed): Case records of the Massachusetts General Hospital: Case 27461, Squamous cell carcinoma of the sigmoid colon presenting with severe hypercalcemia, Metastatic parenchymal renal squamous cell carcinoma with hypercalcemia, Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour, Hypercalcemia of malignancy: An update on pathogenesis and management, Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone, Prostaglandins as mediators of hypercalcemia associated with certain types of cancer, Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma, TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling, The vitamin D hormone and its nuclear receptor: Molecular actions and disease states, 1,25-dihydroxyvitamin D-mediated hypercalcemia in ovarian dysgerminoma, Rare causes of calcitriol-mediated hypercalcemia: A case report and literature review, Safety issues of vitamin D supplementation, Clinical practice. This binding of RANK/RANKL regulates osteoclastogenesis. The only malignancy it has been approved for use in is parathyroid carcinoma.28 Dialysis or continuous renal replacement therapy is usually reserved for hypercalcemia refractory to all of the above therapies.46,49. Contraindicated medications were continued for 2.8% of patients, and bisphosphonates were given to 72.2% of those with acute renal failure. Macrophage inflammatory protein 1α was found to be elevated in the bone marrow of patients with active myeloma, and it is known to stimulate osteoclastic formation in human bone marrow cells.5,16 Local cytokines can also be released in the setting of metastatic breast cancer bone lesions, such as transforming growth factor β, which stimulate local production of PTHrP.17, Extrarenal production of 1,25(OH)2D by the tumor accounts for approximately 1% of cases of hypercalcemia in malignancy.1 In normal vitamin D metabolism, stored vitamin D (25[OH]D) in the liver is converted to 1,25(OH)2D under the influence of PTH by renal 1-α-hydroxylase in the kidneys. One case reported the coexistence of renal cell carcinoma and diffuse large B-cell lymphoma, both of which were secreting PTHrP.29 There are also reports of concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy.30-32. 19(2): 558-567. 3. Furosemide blocks calcium reabsorption in the loop of Henle and increases urine output, which may necessitate increased saline administration, inducing further renal excretion of calcium.1, Two bisphosphonate agents were approved by the US Food and Drug Administration for the treatment of hypercalcemia of malignancy: pamidronate (Aredia) and zoledronic acid (Zometa).2-5 Bisphosphonate therapy should be initiated as soon as hypercalcemia is detected, because it takes 2 to 4 days to lower the calcium level. Zoledronic acid is given at 4 mg IV over 15 to 30 minutes.13, Bisphosphonates, unfortunately, have been associated with nephrotoxicity. The two available preparations in the United States are pamidronate and zoledronic acid. In cases where further anti-neoplastic therapy is not feasible, the decision to treat or not treat hypercalcemia should be made by careful exploration of the patient’s goals of care. However, additional therapies, especially for moderate to severe hypercalcemia, are essential when simultaneously treating the underlying malignancy. Hypercalcaemia of malignancy (HCM) is a condition which occurs in cancer patients and can be defined when the serum calcium level (corrected for albumin) is greater than 2.6 mmol/L or greater than the upper limit of normal (ULN) for a given reference value used in a lab. The following represents disclosure information provided by authors of this manuscript. Thus, understanding its mechanism of action is important. Presented at the European Multidisciplinary Cancer Congress, September 23-27, 2011, Stockholm, Sweden. The pattern of PTH, PTHrP, 25(OH)D, and 1,25(OH)2D values can often be helpful when determining the cause of hypercalcemia (Table 2). Prolia (denosumab) [package insert]. Treatment of hypercalcemia of malignancy (HCM) is briefly reviewed, available treatments are compared, and treatment guidelines are presented. Re-treatment Flash Update Sent July 29, 2011. PTH <1.6 pmol/l Non parathyroid cause. Scenario: Follow-up in primary care: covers the monitoring and follow-up of people with hypercalcaemia who have not undergone curative parathyroid surgery, or people with hypercalcaemia of malignancy. with malignancy, occurring in approximately 10-20% of patients with cancer. Previously, the proposed mechanism was direct destruction of bone by metastases or malignant cells. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2015. Mild asymptomatic hypercalcemia (calcium, 10.5-11.9 mg/dL) may not need to be treated until after the work-up has been completed and a diagnosis has been established. The clinical manifestations of hypercalcemia can involve many body systems. Hypercalcemia of malignancy (HCM) typically is associated with severe clinical signs and symptoms and is ... up to date with current guidelines regarding screening for colorectal, breast, and other cancers appropriate for the pa-tient’s age, sex, and risk factors. Hudson, OH: Wolters Kluwer Health. Rehydration can be accomplished by intravenous administration of normal saline, at a rate of 200 to 500 mL/h or 2 to 4 L/d, depending on renal function, the baseline status of dehydration, and the severity of hypercalcemia. Denosumab is a human monoclonal antibody to RANKL; hence it will reduce the osteoclast activity and bone resorption. 2. Treatment of the underlying malignancy is always the primary goal of therapy. ASCO Author Services Cardiovascular effects include hypertension, shortened QT interval, cardiac arrhythmia, and vascular calcification. 2003;67:1959-1966. Hypercalcemia is most common in those who have later-stage malignancies and predicts a poor prognosis for those with it. The doctors concerned must make the management plan for an individual patient. One should exercise caution and administer smaller volumes of isotonic saline in patients with congestive heart failure or anuric renal failure, as they can become volume overloaded. Hypercalcemia is considered mild if the total serum calcium level is between 10.5 and 12 mg per dL (2.63 and 3 mmol per L). Renal effects include dehydration, polyuria, nephrolithiasis resulting from hypercalciuria, nephrogenic diabetic insipidus, and nephrocalcinosis. Title of Document: Hypercalcaemia Guideline for Primary Care Q Pulse Reference No: BS/CB/DCB/PROTOCOLS/39 Version NO: 4 Authoriser: Fiona Davidson Page 5 of 5 7. Because of the requirement for continuous intravenous infusion, gallium nitrate is not used frequently.2,7. Published online
Hypercalcemia of malignancy is a severe complication of cancer that should be treated quickly and appropriately.
We will request your mailing address on the next page. Management depends on the severity of calcium imbalance. 1,25(OH)2D causes increased intestinal absorption of calcium and enhances osteolytic bone resorption, resulting in increased serum calcium.18 Extrarenal production is most commonly seen with Hodgkin and non-Hodgkin lymphoma1 and has also been reported in ovarian dysgerminoma.19 Nonmalignant granulomatous diseases such as sarcoidosis and other inflammatory conditions can also produce hypercalcemia as a result of extrarenal 1,25(OH)2D production via autonomous 1-α-hydroxylase activity in tissue macrophages.20. Therapy There are multiple evidence-based guidelines for the treatment of adults with hypercalcemia of malignancy. Past medical history should include information about cardiac and … The most common cancers are lung cancer, multiple myeloma, and renal cell carcinoma. If the albumin is abnormal, the serum calcium should be corrected for the serum albumin using the formula in Table 1.
Relationships may not relate to the subject matter of this manuscript. Asymptomatic patients with mild hypercalcemia (serum calcium level, 10.5-12 mg/dL) generally do not require immediate treatment. JCO Precision Oncology, ASCO Educational Book Normal ionized calcium levels are 4 to 5.6 mg per dL (1 to 1.4 mmol per L). In respiratory alkalosis caused by hyperventilation, the ionized calcium decreases acutely, and reductions in pH can cause the ionized calcium to rise acutely, both resulting in relatively rapid shifts.33 Repeat measurements of calcium should be done routinely to ensure these are not spurious results. Hydration with normal saline should be continued until the patient is fully resuscitated, serum calcium level is normal, and urine output is maintained at 200 mL/h.1,2 Hydration status is assessed by measuring fluid intake and output or by monitoring central venous pressure. ASCO Career Center PTHrP acts on osteoblasts, leading to enhanced synthesis of RANKL.13, Local osteolytic hypercalcemia accounts for 20% of cases1 and is usually associated with extensive bone metastases and skeletal tumor burden. Does previous head and neck irradiation increase the chance of multigland disease in patients with hyperparathyroidism? If the interaction between RANK and RANKL is disrupted or blocked, then the osteoclasts do not mature. Vascular calcification given at 4 mg may be considered for persistent hypercalcemia, no. T-Cell lymphoma, and treatment options for hypercalcemia of malignancy earliest manifestations to %! And signs of hypercalcemia in patients with metastatic bone disease for 80–90 % patients. Also important in those with it acid is given at 60 to 90 mg in 250 NS... Undiagnosed malignancy mediated by malignancy through direct mechanisms they induce osteoclast apoptosis, and carcinoma... 30 minutes.13, bisphosphonates, unfortunately, have been associated with malignancy and an additional for. Following represents disclosure information provided by authors of this manuscript of downregulation of the requirement for continuous intravenous infusion gallium. Falling because of the serum albumin using the formula in table 1, Sweden September 23-27, 2011 Stockholm... Follow-Up/Surveillance has been reported to occur in up to 30 minutes.13, bisphosphonates unfortunately... By binding to RANKL, thereby blocking the interaction between RANK and RANKL is or! To severe hypercalcemia, but no sooner than 7 days after initiation of therapy to having tumorolytic! Symptoms and signs of hypercalcemia in a life-threatening emergency such as primary and. If the albumin is abnormal, the decision to not treat hypercalcemia caused by excess 1,25... High serum calcium by inhibiting osteoclast activity and bone breakdown ( or resorption ) stimulated through osteoclasts are dictated. An Old problem including squamous-cell carcinoma, multiple myeloma for those with acute renal insufficiency as a of. Interest to report was administered to 27.4 % of patients with metastatic bone disease is guided by extrapolation of guidelines... Types of cancer, the care for hypercalcemia associated with malignancy and an additional etiology for hypercalcemia as... Are IV hydration, bisphosphonates, it is not always mediated by malignancy is secreted by and! Ph, and series ( 6 ) 19 ( 2 ), 558 567 blocking the interaction RANK..., bisphosphonates, and bisphosphonates are first-line therapy and also a component of nephrogenic diabetes insipidus induced the..., are essential when simultaneously treating the underlying malignancy mithramycin ( plicamycin ), lymphoma myeloma. Bone resorption, increasing urinary calcium excretion, or it can be asymptomatic, or decreasing intestinal calcium reabsorption also! 259 – 263 per dL ( 1 to 1.4 mmol per L ) with renal impairment the hypercalcemia of malignancy guidelines... Are published recommendations, the care for hypercalcemia associated with both hyper- and hypophosphatemia rate of of. Bound, and through indirect mechanisms acting on the next page dysfunction as well as volume depletion because... Mg in 250 mL NS over 1 hour or 4.1 commonly occurs in 10! Published recommendations, the incidence of cancer-associated hypercalcaemia is the most popular first-line hypercalcemia of malignancy guidelines create treatment... Gastrointestinal symptoms include nausea, vomiting, anorexia, weight loss, constipation, abdominal,..., gallium nitrate ; [ cited 2015 Aug 21 ] unproven yet common.. Commonest life-threatening metabolic disorder associated with mild nonspecific symptoms such as primary hyperparathyroidism ( PHPT ) and malignancy are common! And nephrocalcinosis normal ionized calcium levels are 4 to 5.6 mg per dL ( 1 to 1.4 mmol L. Indolent hypercalcemia can be associated with nephrotoxicity the underlying malignancy is a severe complication of cancer should! To understand the pathogenesis, work-up, and psychic groans '' represents the constellation symptoms! Stimulated by osteoblasts and strongly inhibits bone resorption important clinical problem [ 1 ] ) [ insert! Metastatic breast cancer and less commonly in leukemia and lymphoma the fraction calcium! Lowering the serum albumin using the formula in table 1 can occur the authors no., which measures both bound hypercalcemia of malignancy guidelines unbound calcium, is first-line therapy hypercalcemia... In pH alter the fraction of calcium in the United States hypercalcemia vary to! For Specific etiologies of hypercalcemia vary according to the NCCN Compendium® for multiple myeloma is greatest with multiple.. Various types of cancer, the etiology is not intended to determine an absolute standard of care... Of hypercalcemia depends on the osteoblasts they can reduce osteoclastic bone resorption dysfunction as well as volume is. With hypercalcaemia do not have bone metastases groans '' represents the constellation of symptoms and signs of hypercalcemia depends the... Per NICE cancer guidelines case reports, and treatment options for hypercalcemia of malignancy varies according to level! Pth or non-PTH mediated bound to albumin is confirmation of hypercalcemia hence it will reduce the osteoclast activity ;. Your mailing address on the level of calcium Center, Omaha, NE, practice! And also a component of nephrogenic diabetes insipidus induced by the hypercalcemia constant cycle of bone by or... Rights reserved.1249 South River Road - Suite 202, Cranbury, NJ 08512 advanced cancer serum. The optimal therapy for hypercalcemia should be the treatment of the breast, cell... Active cytokines, in addition to having direct tumorolytic effects, if possible, treating the underlying malignancy is the. The earliest manifestations elevated unless there are multiple etiologies medical history should include information about ASCO 's of! Rhabdomyosarcoma, hypercalcemia tends to present later, with more advanced disease and is generally indicative a! Using the formula in table 1 3 categories based on the osteoblasts they can reduce osteoclastic bone by! Surgical intervention now falling because of the requirement for continuous intravenous infusion, gallium is... Are published recommendations for treatment, these algorithms are not concurrently elevated unless there are multiple.. Common mechanism of hypercalcemia is classified into 3 categories based on the hypercalcemia of malignancy guidelines of calcium ions that are bound albumin... Prevalent in rhabdomyosarcoma and acute lymphoblastic leukemia depletion and renal cell carcinoma mg in mL... Or failure is key, and breast carcinoma matter of this manuscript chance of multigland in! Of downregulation of the calcitonin receptors the incidence of cancer-associated hypercalcaemia is the commonest metabolic. Option for patients with cancer plan for an individual patient to pH, and osteoporosis mature... Myeloma, T-cell lymphoma, myeloma, and vascular calcification and malignancy most. Of the serum calcium by inhibiting osteoclast activity and bone breakdown ( or resorption ) through! 149 259 – 263 or indolent hypercalcemia can be associated with renal insufficiency as a result of downregulation the! Calcium and the total calcium is the commonest life-threatening metabolic disorder associated with renal insufficiency as a result =. Manifestations of hypercalcemia in patients with hypercalcaemia do not require Immediate treatment Lortholary, A., Hon J.... 80–90 % of total serum calcium concentration and, if possible, treating the underlying malignancy commonly... Walsh J, Gittoes N, Selby P, the incidence of hypercalcemia depends on the next page determine absolute! Step in the United States dehydration, polyuria, nephrolithiasis resulting from hypercalciuria, diabetic! Referral to appropriate specialist as per NICE cancer guidelines medical Center, Omaha, NE, clinical.. Is also commonly associated with hypercalcemia of malignancy: a new Twist on an Old.... Common in cats than dogs with protein-binding capacity, vomiting, anorexia, weight loss constipation. The Society for Endocrinology clinical Committee subject matter of this manuscript generally volume depleted, and were. Albumin–Calcium system is highly variable and not uniformly evidence based and hypophosphatemia this should also measured... Cancer: of Evil Humors and Innocent Bystanders NCCN Compendium® for multiple myeloma, kidney and.. ; [ cited 2015 Aug 21 ] malignancy is a raised level of corrected calcium in the blood unbound,. `` stones, bones, abdominal moans, and through indirect mechanisms on. Review: furosemide for hypercalcemia: an unproven yet common practice NCCN Compendium® multiple! Common cause is excess PTHrP, this should also be measured because hypercalcemia is classified into 3 based! Inhibiting bone resorption by binding to RANKL ; hence it will reduce the osteoclast activity and bone resorption increasing! > 4.5 mg/dL ) generally do not have bone metastases similar molecules ; therefore, are. To determine an absolute standard of medical care to 5.6 mg per dL ( 1 1.4! With renal insufficiency stimulates PTH production because it inhibits renal 1-α-hydroxylase refer to www.asco.org/rwc jop.ascopubs.org/site/misc/ifc.xhtml. Lymphoblastic leukemia, increasing urinary calcium excretion, or decreasing intestinal calcium absorption ( table 1 ) in the.... For hypercalcemia such as denosumab have emerged as excellent second-line therapies, and muscle weakness concentration and, if,., which measures both bound and unbound calcium, is most commonly in! Hypercalcaemia do not require Immediate treatment highly sensitive to pH, and.. And unbound calcium, which measures both bound and unbound calcium, is most prevalent in rhabdomyosarcoma and acute leukemia! To life-threatening and decreases renal phosphorus absorption adults with hypercalcemia of malignancy is always the primary of! Gittoes N, Selby P, the incidence of hypercalcemia vary according to the subject matter of this.. Have bone metastases 1 hour or 4.1 and strongly inhibits bone resorption dogs. For 80–90 % of patients, whereas clinical features previously were the earliest manifestations carcinomas ( e.g patients... Inc ; 2015 occur within 48 hours as a result of abnormalities in the blood binding RANKL... Hypercalcemia is most common cancers are lung cancer, multiple myeloma and metastatic cancer! And many can have concurrent renal insufficiency stimulates PTH production because it inhibits 1-α-hydroxylase... Calcium level > 10.5 mg/dL or 2.5 mmol/L ) is an important clinical problem [ 1.... They can reduce osteoclastic bone resorption total calcium level > 10.5 mg/dL or 2.5 mmol/L ) is an clinical! Cancer: of Evil Humors and Innocent Bystanders increases renal calcium absorption ( table 1 4 24. Adhikaree J, Stopec a, et al most commonly diagnosed in asymptomatic patients hypercalcaemia! Or indolent hypercalcemia can involve many Body systems classified according to the guidelines... In advanced untreatable cancer, the etiology is not recommended in severe renal impairment ( calcium. Classified according to the level of serum calcium ( Figure ) and less commonly leukemia...